Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

AFLP-AFLP in silico-NGS approach reveals polymorphisms in repetitive elements in the malignant genome.

Koblihova J, Srutova K, Krutska M, Klamova H, Machova Polakova K.

PLoS One. 2018 Nov 8;13(11):e0206620. doi: 10.1371/journal.pone.0206620. eCollection 2018.

2.

BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia.

Srutova K, Curik N, Burda P, Savvulidi F, Silvestri G, Trotta R, Klamova H, Pecherkova P, Sovova Z, Koblihova J, Stopka T, Perrotti D, Polakova KM.

Haematologica. 2018 Dec;103(12):2016-2025. doi: 10.3324/haematol.2018.193086. Epub 2018 Jul 26.

3.

Identification and functional screening of microRNAs highly deregulated in colorectal cancer.

Faltejskova P, Svoboda M, Srutova K, Mlcochova J, Besse A, Nekvindova J, Radova L, Fabian P, Slaba K, Kiss I, Vyzula R, Slaby O.

J Cell Mol Med. 2012 Nov;16(11):2655-66. doi: 10.1111/j.1582-4934.2012.01579.x.

4.

Proceedings: Encephabol in patients with organic brain-syndrome.

Haskovec L, Jirsák R, Srutová K.

Act Nerv Super (Praha). 1974;16(4):259-60. No abstract available.

PMID:
4451004
5.

The action of pyrithioxine in patients with organic encephalopathies.

Haskovec L, Hynek K, Jirák R, Srutová K.

Act Nerv Super (Praha). 1973 May;15(2):121-2. No abstract available.

PMID:
4584772

Supplemental Content

Loading ...
Support Center